Trials / Completed
CompletedNCT02430636
Irreversible Electroporation(IRE) For Unresectable Stomach Neoplasms
Irreversible Electroporation(IRE) For Unresectable Stmoach Neoplasms: Phase I and Phase II Clinical Trial
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 30 (actual)
- Sponsor
- Fuda Cancer Hospital, Guangzhou · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to evaluate the safety and efficacy of irreversible electroporation (IRE) for unresectable Stomach Neoplasms.
Detailed description
By enrolling patients with unresectable Head and Stomach adapted to enrolled criteria, this study will document for the first time the safety and the short and long term efficacy of percutaneous IRE for unresectable Stomach Neoplasms.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Irreversible electroporation (IRE) | Irreversible Electroportion For Unresectable Stomach Neoplasms guide with ultrasound or/and CT. |
| DEVICE | NanoKnife |
Timeline
- Start date
- 2015-01-01
- Primary completion
- 2020-12-01
- Completion
- 2021-02-01
- First posted
- 2015-04-30
- Last updated
- 2021-09-05
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT02430636. Inclusion in this directory is not an endorsement.